Amgen Canada retained H+K Canada to develop and execute a public relations campaign to support the launch of PROLIA®, a unique, targeted treatment for

postmenopausal women with osteoporosis at high risk for fracture. Our challenge was to generate attention for this often overlooked disease.

We launched PROLIA with a national media campaign and eight unbranded public education forums held in partnership with stakeholder groups in communities

across Canada. Ongoing stakeholder engagement and partnership – with Osteoporosis Canada and CARP – helped lay the groundwork for future

advocacy and reimbursement efforts.

Our program exceeded expectations in terms of quantity and quality of coverage; and its success, in large part, was due to the engagement and involvement of

physicians, stakeholders and patients; a mix of controlled media and traditional media outreach tactics; as well as our ongoing consumer awareness campaign.

Overall, we helped Amgen raise awareness of osteoporosis, the current treatment gap and PROLIA as a new treatment option.

A TARGETED APPROACH TO

PROTECTING BONES